Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs) are emerging as compelling alternatives to hospital-based care, offering patients better access at substantially lower cost.
As site-of-care reimbursement evolves and technology matures, peripheral thrombectomy is now becoming economically viable in these settings.
iCHOR Vascular’s iSWEEP platform is accelerating this shift through intentional simplicity: no capital equipment, minimal setup, predictable costs, and rapid procedures.
iSWEEP is giving ASC and OBL operators new opportunities to expand revenues and patient services, without incurring huge upfront investments or having to radically change their established operating models.
Read the full whitepaper: Simplified Mechanical Thrombectomy: A Profitable Reality for ASCs and OBLs
